A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.
about
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses.Novel pharmacotherapies for cardiac amyloidosis.The proteasome and proteasome inhibitors in multiple myeloma.New concepts in the treatment and diagnosis of amyloidosis.A phase I study to assess the mass balance, excretion, and pharmacokinetics of [(14)C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.Light Chain Amyloidosis.Novel Therapies in Light Chain Amyloidosis.Recent advances in understanding and treating immunoglobulin light chain amyloidosis
P2860
Q38627306-C1F5A1B3-FEA0-4348-B85A-CFBCB4D96FCBQ38709793-E16F270F-33AE-4CDD-8B97-1A5D050F0B92Q47339695-82911238-974B-4F6D-A229-4D37FA67F205Q47561519-B7B2E644-35F3-4547-B17D-74CBA9B13B1CQ48317730-EC4D0863-3C8B-4FC9-90ED-18A75917DE04Q52659305-8DB2DD6E-F7E1-4C9F-9FB7-0B1F6F97FF6FQ55127439-FF5A9E1E-C5D0-44FB-95D2-5EC24F40AB1AQ57166910-997DAA73-8C9F-4EF6-89E7-A0A1FCB94172
P2860
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A phase 1/2 study of the oral ...... or refractory AL amyloidosis.
@en
type
label
A phase 1/2 study of the oral ...... or refractory AL amyloidosis.
@en
prefLabel
A phase 1/2 study of the oral ...... or refractory AL amyloidosis.
@en
P2093
P50
P1433
P1476
A phase 1/2 study of the oral ...... d or refractory AL amyloidosis
@en
P2093
Ai-Min Hui
Arnaud Jaccard
David C Seldin
Deborah Berg
Giampaolo Merlini
Huyuan Yang
Jeffrey A Zonder
Neeraj Gupta
Raymond L Comenzo
Vaishali Sanchorawala
P304
P356
10.1182/BLOOD-2017-03-771220
P407
P577
2017-05-26T00:00:00Z